RAPT Therapeutics, Inc. (RAPT) Shares Issued (2020 - 2024)
RAPT Therapeutics' Shares Issued history spans 5 years, with the latest figure at $8.2 million for Q4 2024.
- For Q4 2024, Shares Issued rose 928.01% year-over-year to $8.2 million; the TTM value through Dec 2024 reached $9.0 million, changed N/A, while the annual FY2024 figure was $9.0 million, N/A changed from the prior year.
- Shares Issued for Q4 2024 was $8.2 million at RAPT Therapeutics, up from $701000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $134.8 million in Q2 2021 and bottomed at -$68.9 million in Q2 2020.
- The 5-year median for Shares Issued is $413000.0 (2021), against an average of $7.8 million.
- The largest YoY upside for Shares Issued was 10280.93% in 2022 against a maximum downside of 11817.19% in 2022.
- A 5-year view of Shares Issued shows it stood at $1.2 million in 2020, then tumbled by 65.67% to $413000.0 in 2021, then plummeted by 11817.19% to -$48.4 million in 2022, then skyrocketed by 97.96% to -$989000.0 in 2023, then skyrocketed by 928.01% to $8.2 million in 2024.
- Per Business Quant, the three most recent readings for RAPT's Shares Issued are $8.2 million (Q4 2024), $701000.0 (Q2 2024), and $67000.0 (Q1 2024).